ClinicalTrials.Veeva

Menu

Monitoring of Biopsy-Proven Interstitial Polyomavirus Nephritis in Kidney and Kidney Pancreas Transplant Recipients

University of Cincinnati logo

University of Cincinnati

Status

Completed

Conditions

Polyomavirus

Study type

Observational

Funder types

Other

Identifiers

NCT00374283
POLYOMA

Details and patient eligibility

About

Evaluate techniques for monitoring the course of interstitial therapy for polyomavirus nephritis in kidney and kidney pancreas transplant recipients by monitoring blood, urine, and renal transplant biopsies of patients affected by polyomavirus.

Full description

Evaluate techniques for monitoring the course of interstitial therapy for polyomavirus nephritis in kidney and kidney pancreas transplant recipients by monitoring blood, urine, and renal transplant biopsies of patients affected by polyomavirus.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Recipients of a kidney or kidney pancreas transplant diagnosed with biopsy proven interstitial nephritis due to polyomavirus.
  • Age 18 to 70 years.
  • Capable of providing written informed consent.

Exclusion criteria

  • Age less than 18 years or greater than 70 years.
  • Patient is on chronic warfarin or heparin therapy or has a disease that puts them at risk of bleeding.

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems